Renaissance Technologies LLC Sells 39,000 Shares of Hill-Rom Holdings Inc (HRC)

Renaissance Technologies LLC lowered its stake in Hill-Rom Holdings Inc (NYSE:HRC) by 18.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 169,600 shares of the medical technology company’s stock after selling 39,000 shares during the quarter. Renaissance Technologies LLC owned approximately 0.26% of Hill-Rom Holdings worth $13,502,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of HRC. Independent Portfolio Consultants Inc. grew its stake in Hill-Rom Holdings by 171.5% during the 2nd quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock valued at $107,000 after acquiring an additional 849 shares in the last quarter. Seven Eight Capital LP bought a new stake in shares of Hill-Rom Holdings in the 2nd quarter valued at approximately $127,000. Acrospire Investment Management LLC grew its stake in shares of Hill-Rom Holdings by 43.4% in the 2nd quarter. Acrospire Investment Management LLC now owns 1,983 shares of the medical technology company’s stock valued at $158,000 after buying an additional 600 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Hill-Rom Holdings by 10.2% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,201 shares of the medical technology company’s stock valued at $175,000 after buying an additional 204 shares in the last quarter. Finally, Citigroup Inc. grew its stake in shares of Hill-Rom Holdings by 21.1% in the 2nd quarter. Citigroup Inc. now owns 2,483 shares of the medical technology company’s stock valued at $198,000 after buying an additional 433 shares in the last quarter. 82.63% of the stock is currently owned by hedge funds and other institutional investors.

In related news, SVP Andreas G. Frank sold 6,870 shares of the business’s stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $77.48, for a total value of $532,287.60. Following the completion of the transaction, the senior vice president now directly owns 16,701 shares in the company, valued at approximately $1,293,993.48. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Andreas G. Frank sold 3,940 shares of the business’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $77.84, for a total transaction of $306,689.60. Following the completion of the transaction, the senior vice president now owns 16,701 shares of the company’s stock, valued at $1,300,005.84. The disclosure for this sale can be found here. 2.20% of the stock is currently owned by company insiders.

HRC has been the subject of several analyst reports. Cantor Fitzgerald initiated coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They issued a “neutral” rating and a $86.00 target price for the company. Needham & Company LLC initiated coverage on Hill-Rom Holdings in a report on Thursday, June 29th. They issued a “buy” rating and a $95.00 target price for the company. Morgan Stanley boosted their target price on Hill-Rom Holdings from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Friday, June 30th. Zacks Investment Research lowered Hill-Rom Holdings from a “buy” rating to a “hold” rating in a report on Tuesday, July 11th. Finally, BidaskClub lowered Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Three research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $86.83.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/27/hill-rom-holdings-inc-hrc-stake-lessened-by-renaissance-technologies-llc.html.

Shares of Hill-Rom Holdings Inc (NYSE:HRC) opened at 79.95 on Friday. The firm has a 50-day moving average price of $76.71 and a 200-day moving average price of $76.72. Hill-Rom Holdings Inc has a 12 month low of $50.50 and a 12 month high of $84.65. The company has a market capitalization of $5.27 billion, a PE ratio of 46.59 and a beta of 1.19.

Hill-Rom Holdings (NYSE:HRC) last posted its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.90 by $0.01. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The business had revenue of $689.10 million for the quarter, compared to analysts’ expectations of $695.50 million. During the same period in the previous year, the firm posted $0.81 EPS. The business’s revenue was up 5.1% on a year-over-year basis. On average, equities research analysts predict that Hill-Rom Holdings Inc will post $3.82 EPS for the current year.

About Hill-Rom Holdings

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply